KPTI

Karyopharm Therapeutics (KPTI)

Karyopharm Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:KPTI

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/10	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/06/07	05:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/06/07	05:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/06/04	05:05	PR Newswire (US)	Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/06/02	02:45	PR Newswire (US)	Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/31	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/31	06:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/31	06:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/31	05:44	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/31	05:06	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/30	05:05	PR Newswire (US)	Karyopharm to Participate at the Jefferies Global Healthcare Conference	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/24	05:30	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/15	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/09	05:13	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/09	05:05	PR Newswire (US)	Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/08	20:52	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/08	20:47	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/08	20:30	PR Newswire (US)	Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/08	20:30	PR Newswire (US)	Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/08	05:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/03	05:30	PR Newswire (US)	Karyopharm to Report First Quarter 2024 Financial Results on May 8, 2024	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/05/02	05:05	PR Newswire (US)	Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/04/25	05:01	PR Newswire (US)	Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/04/02	05:05	PR Newswire (US)	Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/03/07	06:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/03/07	06:05	PR Newswire (US)	Karyopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/03/05	09:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/03/05	09:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/03/05	09:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KPTI	Karyopharm Therapeutics Inc
2024/03/05	09:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KPTI	Karyopharm Therapeutics Inc